— The biotech stock rose 2% after Moderna said that it has had enough cases of Covid-19 in its vaccine candidate trial to take a look at the data, signaling that preliminary results could be released soon. The stock also rose more than 8% during normal trading hours Wednesday.— Shares of the fashion retailer fell more than 9% after the company reported a surprise year-over-year decline in net sales for the third quarter.
— Shares of the watchmaker spiked more than 30% after Fossil announced its third-quarter results that included widening margins. The company said it earned an adjusted 31 cents per share on $435.5 million of net sales during the quarter, which was a decline in net sales of 19% year over year. Fossil also said it had more than $300 million in cash and cash equivalents as of Oct. 3.